Larotrectinib

From WikiMD

Information about Larotrectinib

Introduction Larotrectinib is a selective inhibitor of neurotrophin receptor kinase (NTRK) that is used in the therapy of solid tumors harboring NTRK gene fusions.

Liver safety of Larotrectinib

Larotrectinib is associated with a high rate of serum aminotransferase elevations during therapy but has not been linked to instances of clinically apparent liver injury with jaundice.

Mechanism of action of Larotrectinib

Larotrectinib (lar" oh trek' ti nib) is an orally available, small molecule inhibitor of the tropomyosin receptor kinases (TRK-A, -B and -C). The genes of TRK are found to be oncogenic drivers in many solid tumors including gliomas and sarcomas. The tumors harbor a fusion product of the proto-oncogene family and overexpress the neurotrophin receptor kinases which results in abnormal cell growth. Larotrectinib has activity against all three forms of TRK and has been shown to be effective in prolonging progression free survival in children and adults with various solid tumors harboring an NTRK gene fusion.

FDA approval information for Larotrectinib

Larotrectinib received accelerated approval for use in the United States in 2018 for the treatment of advanced or metastatic solid tumors that have NTRK gene fusion.

Dosage and administration for Larotrectinib

Larotrectinib is available in capsules of 25 and 100 mg and as an oral solution of 20 mg/mL under the brand name Vitrakvi. The recommended dose in adults is 100 mg orally twice daily, the dose in children and small adults being adjusted to body surface area.

Side effects of Larotrectinib

Side effects are common and include fatigue, nausea, vomiting, constipation, diarrhea, dizziness and cough. Uncommon, but potentially serious side effects include neurotoxicity (delirium, dysarthria, dizziness, gait disturbance, tremor), hepatotoxicity (ALT and AST elevations) and embryo-fetal toxicity.


The article on Larotrectinib is a stub. YOU can help Wikimd by expanding it!

Medication resources

Learn more


edit 

About WikiMD

About us: WikiMD is a free medical encyclopedia and wellnesspedia moderated by medical professionals.

Our mission: Provide up to date physician reviewed health, nutrition and wellness information for free in over 100 languages.

Join us: This article is a stub. Help improve Larotrectinib or others. Do not trust amateurs with your life! Join us in this effort!. Paid editors welcome.

Pubmed.png Uptodate.png Wikipedia Reddit YouTube videos
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP*

Quick links: Medicine Portal | Encyclopedia‏‎‏‎ | Gray's Anatomy‏‎ | Topics‏‎ |‏‎ Diseases‏‎ | Drugs | Wellness | Obesity‏‎ | Metabolic syndrome | Weight loss*
Disclaimer: The entire contents of WIKIMD.ORG are for informational purposes only and do not render medical advice or professional services. If you have a medical emergency, you should CALL 911 immediately! Given the nature of the wiki, the information provided may not be accurate, misleading and or incorrect. Use the information on this wiki at your own risk! See full Disclaimer.
Link to this page: <a href="http://www.wikimd.org/wiki/Larotrectinib">Larotrectinib</a>

  • Individual results may vary for weight loss from our sponsors.